Epigenetic silencing of DACH1 induces loss of transforming growth factor-β1 antiproliferative response in human hepatocellular carcinoma.
about
The retinal determination gene network: from developmental regulator to cancer therapeutic targetEpigenetic mechanisms in cancer: push and pull between kneaded erasers and fate writersThe DACH/EYA/SIX gene network and its role in tumor initiation and progressionZNF545 suppresses human hepatocellular carcinoma growth by inhibiting NF-kB signaling.DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells.Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signalingEpigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF-β signallingSilencing DACH1 promotes esophageal cancer growth by inhibiting TGF-β signaling.DACH1, a zona glomerulosa selective gene in the human adrenal, activates transforming growth factor-β signaling and suppresses aldosterone secretionEpigenetic silencing BCL6B induced colorectal cancer proliferation and metastasis by inhibiting P53 signaling.DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling.RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant markerEpigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signalingTMEM196 acts as a novel functional tumour suppressor inactivated by DNA methylation and is a potential prognostic biomarker in lung cancer.GRP78 confers the resistance to 5-FU by activating the c-Src/LSF/TS axis in hepatocellular carcinomaCirculating cell-free DNA-based epigenetic assay can detect early breast cancer.An H2A histone isotype regulates estrogen receptor target genes by mediating enhancer-promoter-3'-UTR interactions in breast cancer cells.Decreased DACH1 expression in glomerulopathy is associated with disease progression and severity.Hippo-YAP signaling pathway: A new paradigm for cancer therapy.Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma.Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma.Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.dachshund Potentiates Hedgehog Signaling during Drosophila Retinogenesis.CXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis.ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway.SIX1 and DACH1 influence the proliferation and apoptosis of hepatocellular carcinoma through regulating p53.Review of Markers of Zona Glomerulosa and Aldosterone-Producing Adenoma Cells.The regulation of cytokine signaling by retinal determination gene network pathway in cancerEffect of DACH1 on proliferation and invasion of laryngeal squamous cell carcinoma
P2860
Q26747218-C5CE758B-804D-481D-BF59-9BFF5915BBC0Q28082510-CC8192E0-1A62-4FB1-A9E5-4EB9EE435531Q28263832-AA1606CC-1944-4A0E-9039-6D025DD92E96Q33849703-1EF7334C-9CB7-4614-902E-3C806D36B8D3Q34374689-B2CFFD5A-9641-4805-9822-0802FDD4835DQ34466347-EC108791-7648-43F9-9DA7-9049AC7DBE0FQ34998403-C21503CF-B0E4-469E-A5D9-28093DDFC631Q35152228-2DC804D4-4A5D-4866-A607-394614E260CDQ35288453-ECBA0530-4C4E-410C-BA76-A08AA91B0C6AQ35402307-E222A6D7-9AD9-43A9-9A85-D260BDFB3F9EQ35742423-F17BEA95-F4E8-48EE-934B-E4EDAB69E896Q35786661-4CA96B09-B02C-482D-863F-F7F228E71FB5Q35793851-2C781E2D-1BC9-473E-ADAA-29D82062DC33Q35832183-06BA1F88-5938-4CC0-8A89-C8917DED612EQ36356293-C7B6E63A-747D-44E6-AA07-E3993710FAD9Q36545246-F87F9D51-3F5C-46CB-BC9A-12DAAA606D27Q37517411-BC1F2964-43D9-42E8-8F2E-DED081BD2495Q37631879-004C86CD-4724-4BE9-B388-8C552351BBCDQ37699281-CB9766D5-A539-4BB0-AFFD-8CF3526D2AD8Q38231786-34F4D569-9F4D-4E31-9E38-7B92D1C3F735Q38694104-63D31C6A-0390-499F-8308-28B2C5CA7814Q38964117-3C6D33E3-155C-4156-A781-E14279F5D089Q38982192-00E682DE-6CFF-4B66-9012-270B44B2BA32Q42101943-09DC50C8-DDB0-41F8-BAA6-6A6153465ECDQ42778168-EFBE0BB9-7D4C-4A8D-AFFB-FB9E591162E1Q47136896-76C2669D-89A9-4CF1-A2C9-465FDDE07E58Q50047509-831A3212-5809-40F9-92A0-B43BBC2A98E4Q51783800-23F5BC4F-A26D-425C-AFB9-F29F6048A8F7Q57483942-9871D510-6406-43E2-ABFE-0DA941628016Q59128608-72544568-B0BC-4A2B-982F-FB4B3E7D99A3
P2860
Epigenetic silencing of DACH1 induces loss of transforming growth factor-β1 antiproliferative response in human hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Epigenetic silencing of DACH1 ...... uman hepatocellular carcinoma.
@en
Epigenetic silencing of DACH1 ...... uman hepatocellular carcinoma.
@nl
type
label
Epigenetic silencing of DACH1 ...... uman hepatocellular carcinoma.
@en
Epigenetic silencing of DACH1 ...... uman hepatocellular carcinoma.
@nl
prefLabel
Epigenetic silencing of DACH1 ...... uman hepatocellular carcinoma.
@en
Epigenetic silencing of DACH1 ...... uman hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Epigenetic silencing of DACH1 ...... uman hepatocellular carcinoma.
@en
P2093
Hongbin Zhu
Kongming Wu
Kunyu Jing
Mingzhou Guo
Yunsheng Yang
P2860
P304
P356
10.1002/HEP.26587
P407
P577
2013-10-21T00:00:00Z